Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy
Work
Year: 2017
Type: article
Abstract: Colorectal cancer (CRC) remains one of the leading causes of cancer related deaths in the United States. Currently, there are limited therapeutic options for patients suffering from CRC, none of which... more
Source: Oncotarget
Institutions University of Nebraska Medical Center, Nebraska Medical Center, Boston Medical Center, University Medical Center, Boston University
Cites: 50
Cited by: 23
Related to: 10
FWCI: 2.385
Citation percentile (by year/subfield): 86.08
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold